New research from Plymouth State University and the University of New Hampshire indicates that collecting and bleeding horseshoe crabs for biomedical purposes causes short-term changes in their behavior and physiology that could exacerbate the crabs' population decline in parts of the east coast. Each year, the U.S. biomedical industry harvests the blue blood from almost half a million living horseshoe crabs for use in pharmaceuticals—most notably, a product called Limulus amebocyte lysate (LAL), used to ensure vaccines and medical equipment are free of bacterial contamination. This lifesaving product can only be made from horseshoe crab blood, says researcher Win Watson,...